NanoTemper is a leading brand in the development of biophysical instruments used for evaluating challenging molecular interactions and protein characterization studies in the fields of pharmaceuticals, biotechnology, and academic research. With a focus on providing innovative instruments and technology for biophysical characterizations, NanoTemper offers a range of products and services to meet the needs of scientists and researchers. Their product lineup includes Prometheus, which allows for the characterization of protein stability, Dianthus, a plate-based platform for affinity screening, and Monolith, which enables the determination of binding affinities in solution.

Additionally, NanoTemper offers solutions for biologics, PROTACs, and gene therapy, providing sizing, stability, and profiling information to aid in the selection of the best candidates. With a global presence in 13 countries and a team of over 200 scientists, NanoTemper is committed to collaboration, customer satisfaction, and finding solutions to advance science. By embracing diversity, maintaining an open-minded approach, and prioritizing customers, NanoTemper aims to create a world where every disease is treatable